Loading chat...

NJ S2894

Bill

Status

Introduced

3/4/2024

Primary Sponsor

Linda Greenstein

Click for details

Origin

Senate

2024-2025 Regular Session

AI Summary

  • Creates the New Jersey Active Pharmaceutical Ingredient Regulatory Commission as an independent body within the Department of the Treasury's executive branch
  • Commission consists of 17 members: 8 public members with pharmaceutical/API manufacturing backgrounds appointed by the Governor and legislative leaders, 4 ex officio legislators (non-voting), 3 state agency heads (Health, Economic Development Authority, Commission of Science), and 2 university presidents (non-voting)
  • Primary duties include establishing manufacturing standards and oversight for APIs produced in-state and quality standards for APIs manufactured outside the state, consistent with federal law
  • Commission will promote growth of API manufacturing in New Jersey, focusing on securing federal funding, and serve as liaison between pharmaceutical industry and state/federal governments for grant opportunities
  • Public members serve staggered five-year terms without compensation but receive expense reimbursement; Governor designates chair from among public members and commission appoints its own executive director

Legislative Description

Requires notice of cancellation or nonrenewal of automobile and homeowners insurance policies to be sent by certified mail, return receipt requested.

Commerce

Last Action

Introduced in the Senate, Referred to Senate Commerce Committee

3/4/2024

Committee Referrals

Commerce3/4/2024

Full Bill Text

No bill text available